ALKTERNATE: A pilot study alternating lorlatinib with crizotinib in patients with ALK+ NSCLC and ALK-inhibitor resistance Meeting Abstract
| Authors: | Itchins, M.; Liang, S.; Brown, C.; Barnes, T.; Marx, G.; Chin, V.; Kao, S.; Yip, P. Y.; Mersiades, A. J.; Nagrial, A.; Bray, V.; Peters, G.; Parakh, S.; John, T.; Li, M.; Li, B. T.; McKay, M.; Molloy, M.; O'Byrne, K.; Lee, C.; Gill, A.; Solomon, B. J.; Pavlakis, N. |
| Abstract Title: | ALKTERNATE: A pilot study alternating lorlatinib with crizotinib in patients with ALK+ NSCLC and ALK-inhibitor resistance |
| Meeting Title: | 2023 World Conference on Lung Cancer (IASLC-WCLC) |
| Journal Title: | Journal of Thoracic Oncology |
| Volume: | 18 |
| Issue: | 11 Suppl. |
| Meeting Dates: | 2023 Sep 9-11 |
| Meeting Location: | Singapore |
| ISSN: | 1556-0864 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2023-11-01 |
| Start Page: | S351 |
| End Page: | S352 |
| Language: | English |
| DOI: | 10.1016/j.jtho.2023.09.616 |
| PROVIDER: | EBSCOhost |
| PROVIDER: | cinahl |
| DOI/URL: | |
| Notes: | Meeting Abstract: P2.10-01 -- Source: Cinahl |
